Greenfield-based Elanco Animal Health Inc. disclosed on Monday that it received a subpoena from the U.S. Securities and Exchange Commission on July 1 related to its channel inventory and sales practices prior to mid-2020.
Shares of the Greenfield-based maker of animal feeds and vaccines dove after the firm warned that it’s facing inflationary pressures, increased logistics costs and other headwinds.
Indiana University Health saw its earnings more than double in the first half of the year, to $414 million, compared to a year ago, as patients flocked back to hospitals and clinics, many for procedures they had postponed during the height of the COVID-19 pandemic.
Eskenazi spokesman Tom Surber said the decision to divert ambulance traffic to other hospitals was made “out of an abundance of caution.” The diversion began at around 8 a.m. Wednesday and remains in place, he said.
While rivals Pfizer and Moderna scoop up millions in vaccine profits, Lilly is about to show its hand
Eli Lilly and Co. passed up the chance to develop a vaccine and instead focused on making antibody treatments for patients who were already infected with the coronavirus. That turned out to be a financial whiff. Now all eyes will be on Lilly’s second-quarter earnings, which the company will release early Tuesday.
State health officials say they have no authority to require anyone to get a vaccine, including state employees.
Eli Lilly and Co. confirmed to IBJ on Thursday its mask requirement is effective immediately and is based on recommendations earlier this week from the CDC. Many other large employers, however, are still in a wait-and-see mode on imposing new restrictions on employees.
IBJ talked to Dr. Cole Beeler, an infectious disease specialist at Indiana University Health, about vaccines, the CDC’s mask recommendation and more.
Ascension’s decision to require vaccinations follows similar mandates by all three other major health systems here.
Indiana University Health plans to turn its massive, expanded campus near Methodist Hospital into a destination site and service area for the neighborhood.
Indianapolis’ newest publicly company, Point Biopharma Inc., is the latest player in a field expected to see explosive growth as doctors and researchers look for new ways to shrink tumors.
Franciscan joins two other large hospital systems in central Indiana—Indiana University Health and Community Health Network—in laying down the new health requirement.
Even as some drugmakers, including Indianapolis-based Eli Lilly and Co., are pushing to get experimental drugs approved, federal regulators are still dealing with a huge blowback over the controversial way they reviewed a new Alzheimer’s drug by rival Biogen.
Kinetrex, formed by Citizens Energy in 2013 and sold to a Chicago private equity firm four years later, said it was looking for a larger partner to help it increase its presence in renewable natural gas.
The Indianapolis-based drugmaker said the deal to buy Protomer Technologies could be worth up to $1 billion if the technology meets certain milestones. Lilly did not say how much it was paying up front in cash.
A new report submitted to the Indiana Legislative Council calls for the regulation of “white bagging,” a practice that requires hospitals to buy drugs from an outside pharmacy, which delivers them premixed ahead of time of the patient’s visit. It is a growing practice, aimed at lowering the cost of care, but many providers say it can compromise care.
Gil Peri, a 6-foot, 8-1/2-inch, gregarious administrator with an easy laugh, started his job on June 28, after spending about four years as president and chief operating officer at Connecticut Children’s Medical Center.